In vitro studies of a degradable device for controlled-release of meloxicam

Journal of Clinical Periodontology

Volumn 32, Issue 7, 2005, Pages 773-777

  Çetin, Emel Ö ^a   Buduneli, Nurcan ^a   Atlihan, Evren ^a   Kirilmaz, Levent ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Controlled drug delivery; Gelatin matrix; Meloxicam; Periodontal disease; Rate measurements

Indexed keywords

ANTIINFLAMMATORY AGENT; BUFFER; GELATIN; MELOXICAM;

ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DENTAL CARE; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL ASSESSMENT; PATHOGENICITY; PERIODONTICS; PERIODONTITIS; SPECTROPHOTOMETRY;

ABSORBABLE IMPLANTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; DELAYED-ACTION PREPARATIONS; DENTAL PLAQUE; GELATIN; HYDROGEN-ION CONCENTRATION; KINETICS; PERIODONTITIS; PHOSPHATES; SALIVA, ARTIFICIAL; THIAZINES; THIAZOLES; WATER;

EID: 21544437904     PISSN: 03036979     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-051X.2005.00755.x     Document Type: Article

References (26)

1. Bezerra, M. M., Lima, V., Alencar, V. B. M., Vieira, I. B., Brito, G. A., Ribeiro, R. A. & Rocha, F. A. (2000) Selective cyclooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. Journal of Periodontology 71, 1009-1014.
2. Brooks, P., Emery, P., Evans, J. F., Fenner, H., Hawkey, C. J., Patrono, C., Smolen, J., Breedveld, F., Day, R., Dougados, M., Enrich, E. W., Gijon-Banos, J., Kvien, T. K., Van Rijswijk, M. H., Warner, T. & Zeidler, H. (1999) Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology 38, 779-788.
3. Buduneli, N., Vardar, S., Atilla, G., Aksu, G., Kütükç üler, N. & Baylas, H. (2001) Gingival crevicular fluid IL-4, IL-6, IFN-γ and TGF-β1 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. Ankara Üniversitesi Dişhekimliǧi Fakültesi Dergisi 28, 161-169, (in Turkish).
4. Buduneli, N., Vardar, S., Atilla, G., Sorsa, T., Luoto, H. & Baylas, H. (2002) Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. Journal of Periodontology 73, 103-109.
5. Çetin, E. Ö., Buduneli, N., Atlihan, E. & Kirilmaz, L. (2004) In vitro studies on controlled-release cellulose acetate films for local delivery of chlorhexidine, indomethacin, and meloxicam. Journal of Clinical Periodontology 31, 1117-1121.
6. Engelhardt, G. (1996) Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. British Journal of Rheumatology 35 (Suppl. 1), 4-12.
7. Golub, L. M., Suomalainen, K. & Sorsa, T. (1992) Host modulation with tetracyclines and their chemically-modified analogs. Current Opinion in Dentistry 2, 80-90.
8. Goodson, J. (1989) Pharmacokinetic principles controlling efficacy of oral therapy. Journal of Dental Research 68, 625-632.
9. Guidance for industry, Dissolution testing of immediate release solid oral dosage forms. Available at: "http://www.fda.gov/cder/guidance/1713bp1. pdf". Accessed on December 20, 2004.
10. Howell, T. H. & Williams, R. C. (1993) Nonsteroidal anti-inflammatory drugs as inhibitors of periodontal disease progression. Critical Reviews in Oral Biology and Medicine 4, 177-196.
11. Jeffcoat, M. K., Williams, K. C., Reddy, M. S., English, R. & Goldhaber, P. (1988) Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. Journal of Periodontal Research 23, 381-385.
12. Keenan, T. R. (1997) Gelati. In: Domb, A. J., Kost, J. & Wiseman, D. M. (eds) Handbook of Biodegradable Polymers, pp. 307-317. Amsterdam: Harwood Academic Publishers.
13. Kelm, G. R., Buchanan, W., Meredith, M. P., Offenbacher, S., Mankodi, S. M., Dobrozsi, D. J., Bapat, N. V., Collins, J. G., Wehmeyer, K. R., Eichhold, T. H. & Doyle, M. J. (1996) Evaluation of ketorolac concentrations in plasma and gingival crevicular fluid following topical treatment with oral rinses and dentifrices. Journal of Pharmaceutical Sciences 85, 842-847.
14. May, N., Epstein, J. & Osborne, B. (2001) Selective COX-2 inhibitors: a review of their therapeutic potential and safety in dentistry. Oral Surgery, Oral Medicine, Oral Radiology and Endodontics 92, 399-105.
15. Notari, R. E. (1971) Biopharmaceutics and Pharmacokinetics: An Introduction, pp. 245-277. New York, NY: Marcel Dekker Inc.
16. Offenbacher, S., Odle, B. M., Gray, R. C. & Van Dyke, T. E. (1984) Crevicular fluid prostaglandin E levels as a measure of periodontal disease status of adult and juvenile periodontitis patients. Journal of Periodontal Research 19, 1-13.
17. 2 levels as a predictor of periodontal attachment loss. Journal of Periodontal Research 21, 101-112.
18. Osiri, M. & Moreland, L. W. (1999) Specific cyclooxygenase 2 inhibitors: a new choice of nonsteroidal anti-inflammatory drug therapy. Arthritis Care and Research 12, 351-362.
19. Reddy, M. S., Palcanis, K. G., Barnett, M. L., Heigh, S., Charles, C. H. & Jeffcoat, M. K. (1993) Efficacy of meclofenomate sodium (Meclomen) in the treatment of rapidly progressive periodontitis. Journal of Clinical Periodontology 20, 635-640.
20. 2 on macrophages and osteoclasts in cultured fetal long bones. Cell and Tissue Research 207, 341-346.
21. Vane, J. R. & Botting, R.M (1998) Anti-inflammatory drugs and their mechanism of action. Inflammation Research 47 (Suppl. 2), S78-S87.
22. Wade, A. & Weller, P. J. (1994) Handbook of Pharmaceutical Excipients, pp. 199-201. Washington DC: American Pharmaceutical Association.
23. Wahl, L.M & Corcoran, M. L. (1993) Regulation of monocyte/macrophage metalloproteinase production by cytokines. Journal of Periodontology 64, 467-473.
24. Wahl, L.M & Mergenhagen, S. E. (1988) Regulation of monocyte/macrophage collagenase. Journal of Oral Pathology 17, 452-455.
25. Warner, T. D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J. A. & Vane, J. R. (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences in the United States of America 96, 7563-7568.
26. Zhang, F., Engebretson, S. P., Morton, R. S., Cavanaugh, P. F., Subbaramaiah, K. & Dannenberg, A. J. (2003) The overexpression of cyclo-oxygenase-2 in chronic periodontitis. Journal of American Dental Association 134, 861-867.